Celo.Cardiomyocytes

About Celogics

Celogics operates as a specialized provider of research-use-only human iPSC-derived cell products, primarily cardiomyocytes, under its Celo.Cells brand. The company leverages proprietary differentiation protocols to produce cells that closely mimic human cardiac electrophysiology for use in 2D, 3D, and organoid systems. Its core value proposition centers on rigorous quality control, validated data, and reliable communication to serve pharmaceutical and academic research clients. Celogics is a private company positioning itself as a trusted partner in the preclinical research tools segment of the cell and gene therapy ecosystem.